The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

High Potency Pancreatin Pharmaceutical Compositions - EP3003360

The patent EP3003360 was granted to Allergan Pharmaceuticals on Oct 7, 2020. The application was originally filed on Nov 5, 2014 under application number EP14859866A. The patent is currently recorded with a legal status of "Revoked".

EP3003360

ALLERGAN PHARMACEUTICALS
Application Number
EP14859866A
Filing Date
Nov 5, 2014
Status
Revoked
Mar 8, 2024
Publication Date
Oct 7, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

CAMULONJul 6, 2021ELLISADMISSIBLE

Patent Citations (19) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2001046493
DESCRIPTIONUS2004057944
DESCRIPTIONUS6051220
DESCRIPTIONWO2006044529
INTERNATIONAL-SEARCH-REPORTUS5750104
INTERNATIONAL-SEARCH-REPORTWO2004074470
OPPOSITIONEP3024479
OPPOSITIONUS3168448
OPPOSITIONUS3223594
OPPOSITIONWO2007014896
OPPOSITIONWO2015019198
SEARCHCN103060296
SEARCHEP0115023
SEARCHGB2234973
SEARCHGB732951
SEARCHUS2004057944
SEARCHUS2006198838
SEARCHUS5075231
SEARCHWO2015019198

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents